159 related articles for article (PubMed ID: 18978559)
21. [The role of thoracoscopy in the diagnosis and management of pleural effusion].
Zhang D; Niu S; Tu C
Zhonghua Nei Ke Za Zhi; 1996 Jun; 35(6):367-70. PubMed ID: 9387621
[TBL] [Abstract][Full Text] [Related]
22. The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysis.
Fletcher SV; Clark RJ
Respir Med; 2007 May; 101(5):1021-5. PubMed ID: 17088053
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in patients presenting with pleural effusion revealing malignancy.
Anevlavis S; Kouliatsis G; Sotiriou I; Koukourakis MI; Archontogeorgis K; Karpathiou G; Giatromanolaki A; Froudarakis ME
Respiration; 2014; 87(4):311-6. PubMed ID: 24457947
[TBL] [Abstract][Full Text] [Related]
24. Homocysteine: new tumor marker in pleural fluid.
Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
[TBL] [Abstract][Full Text] [Related]
25. Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis.
Rodríguez-Panadero F; López Mejías J
Am Rev Respir Dis; 1989 Mar; 139(3):663-7. PubMed ID: 2923367
[TBL] [Abstract][Full Text] [Related]
26. Medical thoracoscopy.
Casal RF; Eapen GA; Morice RC; Jimenez CA
Curr Opin Pulm Med; 2009 Jul; 15(4):313-20. PubMed ID: 19387349
[TBL] [Abstract][Full Text] [Related]
27. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
28. [The diagnostic value of medical thoracoscopy for unexplained pleural effusion].
Jiang SJ; Mu XY; Zhang S; Su LL; Ma WX
Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):337-40. PubMed ID: 24047806
[TBL] [Abstract][Full Text] [Related]
29. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
30. Thoracoscopy for pleural space disease.
Greene PS; Heitmiller RF
Surg Laparosc Endosc; 1994 Apr; 4(2):100-2. PubMed ID: 8180758
[TBL] [Abstract][Full Text] [Related]
31. [Thorascopy as a diagnostic and therapeutic precaution in lung and pleural diseases].
Kopp C; Perruchoud A; Schwander R; Herzog H
Schweiz Med Wochenschr; 1979 Mar; 109(13):478-80. PubMed ID: 432580
[TBL] [Abstract][Full Text] [Related]
32. Thoracic ultrasound prior to medical thoracoscopy improves pleural access and predicts fibrous septation.
Medford AR; Agrawal S; Bennett JA; Free CM; Entwisle JJ
Respirology; 2010 Jul; 15(5):804-8. PubMed ID: 20456669
[TBL] [Abstract][Full Text] [Related]
33. Outcome of medical thoracoscopy.
Tscheikuna J; Silairatana S; Sangkeaw S; Nana A
J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S19-23. PubMed ID: 19562981
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
35. Medical thoracoscopy.
Skalski JH; Astoul PJ; Maldonado F
Semin Respir Crit Care Med; 2014 Dec; 35(6):732-43. PubMed ID: 25463164
[TBL] [Abstract][Full Text] [Related]
36. [Thoracoscopy in malignant pleural effusions].
Zhang D; Chen Y; Tu C
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):123-6. PubMed ID: 9206045
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value and Therapeutic Implications of Pleural Carcinosis and Malignant Pleural Effusion in Advanced Epithelial Ovarian Cancer.
Nasser S; Fotopoulou C; Richter R; Kaulich J; Braicu E; Beteta C; Olschewski J; Babayeva A; Sehouli J
Anticancer Res; 2021 Apr; 41(4):2033-2038. PubMed ID: 33813410
[TBL] [Abstract][Full Text] [Related]
38. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
Bielsa S; Esquerda A; Salud A; Montes A; Arellano E; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2009 Jul; 20(4):383-6. PubMed ID: 19524179
[TBL] [Abstract][Full Text] [Related]
39. [Thoracoscopy--the method of choice in the determination of a malignancy as the cause of pleural effusion of unknown etiology].
Guska S
Med Arh; 2002; 56(4):213-6. PubMed ID: 12518537
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
